(Q36368481)

13 August 2017

Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells (English)

1 reference

13 August 2017

1 reference

9

1 reference

13 August 2017

M Tenan

1

1 reference

13 August 2017

G Fulci

2

1 reference

13 August 2017

M Albertoni

3

1 reference

13 August 2017

A C Diserens

4

1 reference

13 August 2017

M F Hamou

5

1 reference

13 August 2017

M El Atifi-Borel

6

1 reference

13 August 2017

J J Feige

7

1 reference

13 August 2017

M S Pepper

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Journal of Experimental Medicine

13 August 2017

1 reference

13 August 2017

191

1 reference

13 August 2017

1789-1798

1 reference

13 August 2017

10

1 reference

Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Regulation of tumor growth and metastasis by thrombospondin-1.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

WAF1, a potential mediator of p53 tumor suppression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Analysis of the p53 gene and its expression in human glioblastoma cells

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Isolation and properties of a thrombin-sensitive protein of human platelets.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Human glioblastoma cells release interleukin 6 in vivo and in vitro

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Identification of an Inhibitor of Neovascularization from Cartilage

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2193158

In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor.

28 June 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Methylation and silencing of the Thrombospondin-1 promoter in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Mechanism of the erythropoietic effect of cobalt

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.191.10.1789

The structure of human platelet thrombospondin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10811871

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Thrombospondin, a potentiator of tumor cell metastasis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10811871

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10811871

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1084/JEM.191.10.1789

1 reference

13 August 2017

1 reference

13 August 2017

1 reference